2 min read
Home >
Blog
8 min read
Regulatory Insights on COVID-19 Updates From FDA | 31 March 2020
March 23, 2020
FDA UPDATES - For Sponsors with Products Intended to Treat Indications Other than COVID-19
In this unique time, with many health authorities, governments and pharmaceutical companies focused on the global pandemic and how to prevent, diagnose and...
2 min read
Covid-19 Update from FDA | Conduct of Clinical Trials During Covid-19 Outbreak
March 19, 2020
FDA Guidance On Clinical Trial Conduct During COVID-19 Pandemic - 18 March 2020
3 min read
Regulatory Guidance Monthly Review - February 2020
March 3, 2020
February 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
3 min read
Regulatory Guidance Monthly Review - January 2020
February 4, 2020
January 2020
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
2 min read
Regulatory Guidance Monthly Review - December 2019
January 7, 2020
December 2019
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical...
4 min read
Regulatory Guidance Monthly Review - November 2019
December 11, 2019
November 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
4 min read
Selecting the Right EDC System for a Clinical Program
November 14, 2019
Understanding the Various Considerations for EDC Selection
3 min read
Regulatory Guidance Monthly Review - October 2019
November 6, 2019
October 2019 Updates from FDA
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug,...
3 min read
Evolving Risk-Based Monitoring to Improve Clinical Studies
October 11, 2019